The cobas SARS-CoV-2 Variant Set 1 Test is designed to detect key spike mutations in virus variants associated with increased human-to-human transmission
AMSBIO is advancing stem cell discovery with the GenePORTER 2 reagent for transfection
AMSBIO has found a reagent to best transfect its human embryonic stem cells
Promega enters global collaboration with Merck to develop Microsatellite Instability (MSI) companion diagnostic for use with KEYTRUDA®
New single-cell analysis technology provides significantly increased capture efficiencies and sensitivity
AMSBIO has introduced new CRISPR / Cas9 editing kits for gene knock-out, gene knock-in and gene mutation applications
First-to-market reagents enable native gene overexpression for meaningful gain-of-function studies
Direct comparative studies now possible with a set of cancer-specific genes for DNA from tumor tissue or for circulating tumor DNA from liquid biopsy samples
TATAA Biocenter also to introduce Swift Biosciences’ NGS products in its popular NGS training courses
